HOLOCENE ADVISORS, LP – Alnylam Pharmaceuticals, Inc. Transaction History
HOLOCENE ADVISORS, LP portfolio value:
$59.92M
portfolio value
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | call | 0.00% | 0 shares | 16.26M | $200.16 | 299.4K | |
| Q3 2022 | share | Increase | 0.00% | 643.64K shares | 128.83M | $200.16 | 643.64K |
| Q2 2022 | call | Increase | 0.00% | 299.4K shares | 43.66M | $145.85 | 299.4K |
| Q2 2022 | share | Decrease | -100.00% | -799.22K shares | -130.50M | $145.85 | 0 |
| Q1 2022 | call | Decrease | -100.00% | -192.5K shares | -32.64M | $163.29 | 0 |
| Q1 2022 | share | Increase | +10.58% | 76.48K shares | 7.94M | $163.29 | 799.22K |
| Q4 2021 | share | Increase | +9.30% | 61.50K shares | -2.28M | $171.03 | 722.73K |
| Q4 2021 | call | Decrease | -66.46% | -381.5K shares | -75.73M | $171.03 | 192.5K |
| Q3 2021 | share | Increase | +19.09% | 105.99K shares | 30.72M | $188.81 | 661.23K |
| Q3 2021 | call | Increase | +134.29% | 329K shares | 66.84M | $188.81 | 574K |
| Q2 2021 | call | Increase | 0.00% | 245K shares | 41.53M | $169.52 | 245K |
| Q2 2021 | share | Increase | 0.00% | 555.23K shares | 94.12M | $169.52 | 555.23K |
| Q4 2019 | share | Decrease | -100.00% | -117.98K shares | -9.48M | $115.17 | 0 |
| Q3 2019 | share | Increase | 0.00% | 117.98K shares | 9.48M | $80.42 | 117.98K |